Previous 10 | Next 10 |
Williamsville, NY, Nov. 04, 2019 (GLOBE NEWSWIRE) -- WILLIAMSVILLE, NY -- 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced...
What a train wreck! That's the best way to describe how marijuana stocks performed during the month of September. Though historically a rough month for the stock market anyway, it was a brutal month for the high-growth cannabis industry . How bad, you ask? The Horizons Marijuana Life Sciences...
"Best" is a relative term. The best option between breaking your leg, your arm, or your nose still isn't a very good choice. It's not quite that bad when it comes to finding the best marijuana stocks of September, but the scenario isn't nearly as good as it's been in the past. Of the three best...
Over the long run, legal marijuana could prove to be a big-time moneymaker for investors . After logging $10.9 billion in legal global sales in 2018, according to Arcview Market Research and BDS Analytics, the legal pot industry could see annual worldwide sales soar to anywhere between $50 bill...
On one hand, legal marijuana could prove to be one of the fastest-growing industries on the planet over the next decade. If investment bank Stifel's forecast of $200 billion in annual worldwide sales in 10 years proves accurate, we could be looking at a compound annual growth rate for cannabis...
August was a dismal month for most marijuana stocks. More than half a dozen pot stocks with market caps greater than $200 million plunged 20% or more during the last month. Several others fell by double-digit percentages. But there were a few exceptions to the August carnage. Three marijuana st...
Recently, an article came out on Seeking Alpha that said some of 22 nd Century Group’s ( XXII ) most important patents had expired and that more expirations were imminent. The patents in question had and have to do with growing its very-low-nicotine (VLN) tobacco. As you may know, th...
22nd Century Group, Inc. (XXII) Q2 2019 Results Earnings Conference Call August 08, 2019, 04:00 PM ET Company Participants Thomas James - Vice President, General Counsel and Corporate Secretary Cliff Fleet - Chief Executive Officer John Brodfuehrer - Chief Financial Officer Co...
22nd Century (NYSEMKT: XXII ): Q2 GAAP EPS of -$0.06. More news on: 22nd Century Group, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine Content tobacco and hemp/cannabis research, announced today that the Company filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...